Biomarker testing patterns and use of targeted therapy in Medicare Fee-for-Service (FFS) beneficiaries newly diagnosed with metastatic non-small cell lung cancer (mNSCLC).

被引：0
|
作者：
Patel, Anik
Jamotte, Aurelien
Matsuda, Tara
Das, Partha Manas
Elkhouly, Ehab
Xi, Ann
Jones, Barton
Murunga, Anne
Petrilla, Allison
Markward, Nathan
Stevinson, Kendall Lee
机构：
[1] Amgen Inc, Global Hlth Econ, Thousand Oaks, CA USA
[2] Amgen Europ, Econ Modeling CoE PACE, Rotkreuz, Switzerland
[3] Amgen Inc, US Med, Thousand Oaks, CA USA
[4] Amgen Inc, Global Med, Thousand Oaks, CA USA
[5] Avalere Hlth, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 29期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
278
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Molecular Biomarker Testing and Initiation of Targeted Therapy in Minority Patients with Stage IV Non-small Cell Lung Cancer
    Villanueva, M.
    Brice, K.
    Dumais, K.
    Uribe, C. R. Carracedo
    Nano, O.
    Rodriguez, M.
    Osmon, E.
    Raez, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S452 - S452
  • [42] PD-L1 expression as a predictive biomarker for chemotherapy response in metastatic non-small cell lung cancer (mNSCLC)
    Woodford, R.
    Lee, C. K.
    Cooper, W.
    Lewis, C.
    John, T.
    Lord, S.
    Marschner, I.
    Zhou, D.
    Yang, J. C-H.
    ANNALS OF ONCOLOGY, 2020, 31 : S874 - S875
  • [43] Predictors of radiation therapy (RT) use among Medicare patients with metastatic non-small cell lung cancer (NSCLC)
    Kim, Miranda
    Schrag, Deborah
    Li, Ling
    Chen, Aileen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [44] Variations in Use of PET among Medicare Beneficiaries with Non-Small Cell Lung Cancer, 1998-2007
    Dinan, Michaela A.
    Curtis, Lesley H.
    Carpenter, William R.
    Biddle, Andrea K.
    Abernethy, Amy P.
    Patz, Edward F., Jr.
    Schulman, Kevin A.
    Weinberger, Morris
    RADIOLOGY, 2013, 267 (03) : 807 - 817
  • [45] Biomarker Testing and Associated Treatment patterns in Advanced Non-Small Cell Lung Cancer in the US
    Last, M.
    Burlison, H.
    Chandrasekar, S.
    Wong, C. Hooi
    Bailey, H.
    Forshaw, C.
    Foley, G.
    Duncan, K.
    Krulewicz, S.
    Wiltshire, R.
    Thomaidou, D.
    Iadeluca, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E26 - E26
  • [46] Immunotherapy as a targeted therapy in non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Avellino, Aniello
    Montesarchio, Vincenzo
    Battiloro, Ciro
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S70 - S75
  • [47] Oral targeted therapy for non-small cell lung cancer
    Phillips, William J.
    Leighl, Natasha B.
    Blais, Normand
    Wheatley-Price, Paul
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (22) : E770 - E774
  • [48] The role of targeted therapy in non-small cell lung cancer
    Maione, P
    Rossi, A
    Airoma, G
    Ferrara, C
    Castaldo, V
    Gridelli, C
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 51 (01) : 29 - 44
  • [49] Targeted Therapy in Non-Small Cell Lung Cancer A Commentary
    Murer, Bruno
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (10) : 1573 - 1575
  • [50] Targeted therapy in the treatment of non-small cell lung cancer
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S13 - S14
12345